Skip to main content

Leong Justin's Form 4 filing

Resmed Inc (RMD) · filed Nov 23, 2022

Accession no.
0001127602-22-026349
Filed
Nov 23, 2022
Trade date
Nov 22-23, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $866.8K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Leong JustinCIK 0001825782Officer (President, Asia Latin America)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 22, 2022ReMed Common StockMOption exerciseAcquired+15,000$57.76+$866,40063,594Direct
Nov 22, 2022ReMed Common StockSSaleDisposed−3,777$229.50F1−$866,821.559,817Direct
Nov 23, 2022ReMed Common StockAGrant or awardAcquired+6,924$0.00$066,741Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 22, 2022ResMed Common StockMOption exerciseDisposed−15,000$0.00$00Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This transaction was executed in multiple trades at prices ranging from $229.42 $229.56. The price reported above reflects the weighted average sale price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)